NCT03932188

Brief Summary

This study assesses brain connectivity and function of individuals ages 13-25 at a prodromal or early stage of a psychotic disorder. Participation involves approximately 3 hours of MRI scanning and up to 6 hours of behavioral testing at Washington University School of Medicine's campus.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 26, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 30, 2019

Completed
1.3 years until next milestone

Study Start

First participant enrolled

September 1, 2020

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 19, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 19, 2021

Completed
Last Updated

November 25, 2020

Status Verified

November 1, 2020

Enrollment Period

10 months

First QC Date

April 26, 2019

Last Update Submit

November 24, 2020

Conditions

Keywords

early psychosisprodromeschizophreniapsychosis

Outcome Measures

Primary Outcomes (1)

  • MRI Brain Imaging

    The current project aims to uncover latent, homogenous, connectivity phenotypes using neuroimaging tools, which are free from the limitations of traditional diagnostic boundaries, and which correlate with clinical characteristics. The investigator will use resting state functional connectivity MRI (rs-fcMRI), diffusion MRI (dMRI) and tract-based spatial statistics (TBSS) to identify brain signatures that cut across psychotic disorders, including schizophrenia.

    within one month of study enrollment

Secondary Outcomes (1)

  • DNA testing through saliva

    within one month of study enrollment

Other Outcomes (1)

  • Hair sample for cortisol measurement

    within one month of study enrollment

Study Arms (2)

Control

Individuals between 13-25 years old that do not meet criteria for any prodromal syndrome, any current or past psychotic disorder, or Cluster A personality disorder diagnosis

Behavioral: Mental Health Assessments and Computerized Cognitive TestDevice: MRI scan

Prodromal/Early psychosis

Individuals between 13-25 years old that meet diagnostic criteria for a prodromal syndrome or early psychosis

Behavioral: Mental Health Assessments and Computerized Cognitive TestDevice: MRI scan

Interventions

Participants will be asked to complete questionnaires and will be asked questions that address a broad range of personal life experiences involving social, occupational, domestic, and other behaviors.

ControlProdromal/Early psychosis
MRI scanDEVICE

Up to two MRI scan sessions will be done, altogether totaling just under 3 hours of scanning. MR scanners measure brain anatomy and activity using very strong magnets. No X-rays or radiation are involved.

ControlProdromal/Early psychosis

Eligibility Criteria

Age13 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Individuals aged 13-25 years who have met criteria for a psychosis-risk syndrome or at a very early stage of a psychotic disorder, such as schizophrenia or schizoaffective disorder.

You may qualify if:

  • Male or female between the ages of 13 and 25
  • Meet diagnostic criteria for a prodromal syndrome or early psychosis by either meeting: 1) criteria for psychosis-risk on the structured assessment of psychosis-risk syndrome, or 2) meeting criteria for a psychotic disorder on the SCID diagnostic interview only within the last 3 years.
  • Understand and sign an informed consent (or assent form for minors) document in English

You may not qualify if:

  • IQ of 70 or under
  • Past or current history of clinically significant central nervous system disorder that may contribute to psychotic symptoms or confound their assessment
  • Pregnancy
  • The diagnostic symptoms are clearly caused by an Axis I disorder, including substance use disorders, as judged by the evaluating clinician.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

MeSH Terms

Conditions

DepressionPsychotic DisordersPersonality DisordersSubstance-Related DisordersSchizophrenia

Interventions

Magnetic Resonance Imaging

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorSchizophrenia Spectrum and Other Psychotic DisordersMental DisordersChemically-Induced Disorders

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 26, 2019

First Posted

April 30, 2019

Study Start

September 1, 2020

Primary Completion

June 19, 2021

Study Completion

June 19, 2021

Last Updated

November 25, 2020

Record last verified: 2020-11

Locations